Table 2.
All patient | In-patient | Out-patient (n = 59) | P value | ||
---|---|---|---|---|---|
(n = 124) | (n = 65) | ||||
Demographics | Male (%) | 83 (66.9) | 45 (69.2) | 38 (64.4) | 0.703 |
Age (month) (median; IQR) | 12.65 (5.7–24.3) | 6.07 (3.1–11.7) | 25.34 (15.5–38.2) | < 0.001 | |
Clinical diagnosis | Bronchiolitis (%) | 73 (58.9) | 37 (56.9) | 36 (61) | 0.716 |
Pneumonia (%) | 23 (18.5) | 23 (35.4) | 0 | < 0.001 | |
Clinical symptoms | Fever (%) | 38 (30.6) | 29 (44.6) | 9 (15.3) | < 0.001 |
Runny nose (%) | 104 (83.9) | 55 (84.6) | 49 (83.1) | 1 | |
Cough (%) | 123 (99.2) | 64 (98.5) | 59 (100) | 1 | |
Co-infectiona | Rhinovirus (%) | 85 (68.5) | 63(96.9) | 22 (37.3) | < 0.001 |
Respiratory syncytial virus (%) | 34 (27.4) | 27 (41.5) | 7 (11.9) | < 0.001 | |
Adenovirus (%) | 17 (13.7) | 5 (7.7) | 12 (20.3) | 0.065 | |
Parainfluenza (%) | 11 (8.9) | 6 (9.2) | 5 (8.5) | 1 | |
Human metapeumovirus (%) | 11 (8.9) | 3 (4.6) | 8 (13.6) | 0.114 | |
Human bocavirus (%) | 8 (6.5) | 6 (9.2) | 2 (3.4) | 0.278 | |
Human coronavirus [HCoV] (%) | 5 (4) | 3 (4.6) | 2 (3.4) | 1 | |
Influenza virus (%) | 3 (2.4) | 0 | 3 (5.1) | 0.105 | |
Parechovirus [PEV] (%) | 1 (0.8) | 1 (1.5) | 0 | 1 | |
Outcome | Death (%) | 0 | 0 | 0 | NA |
Note: aindicates confirmed by specific (RT)PCR; NA not applicable, IQR interquartile range